BRITANNIA TIGER HEALTH LTD

Company Registration Number:
14702720 (England and Wales)

Unaudited statutory accounts for the year ended 31 March 2025

Period of accounts

Start date: 01 April 2024

End date: 31 March 2025

BRITANNIA TIGER HEALTH LTD

Contents of the Financial Statements

for the Period Ended 31 March 2025

Company Information - 3
Report of the Directors - 4
Balance sheet - 5
Additional notes - 7
Balance sheet notes - 10

BRITANNIA TIGER HEALTH LTD

Company Information

for the Period Ended 31 March 2025




Director: Sergey Belousov
Igor Zharkov
Registered office: 85
Great Portland Street
London
England
W1W 7LT
Company Registration Number: 14702720 (England and Wales)

BRITANNIA TIGER HEALTH LTD

Directors' Report Period Ended 31 March 2025

The directors present their report with the financial statements of the company for the period ended 31 March 2025

Principal Activities

Sale of vitamins online

Political and charitable donations

None

Directors

The directors shown below have held office during the whole of the period from 01 April 2024 to 31 March 2025
Sergey Belousov
Igor Zharkov

This report was approved by the board of directors on 7 December 2025
And Signed On Behalf Of The Board By:

Name: Sergey Belousov
Status: Director

Name: Igor Zharkov
Status: Director

BRITANNIA TIGER HEALTH LTD

Balance sheet

As at 31 March 2025


Notes

2025
£
13 months to
31 Mar 2024
£
Fixed assets
Tangible assets: 1,124
Total fixed assets: 1,124
Current assets
Stocks: 41,994 3,000
Debtors: 4 690 696
Cash at bank and in hand: 52,987 15,517
Total current assets: 95,671 19,213
Creditors: amounts falling due within one year: 5 ( 51,847 ) ( 5,689 )
Net current assets (liabilities): 43,824 13,524
Total assets less current liabilities: 43,824 14,648
Total net assets (liabilities): 43,824 14,648

The notes form part of these financial statements

BRITANNIA TIGER HEALTH LTD

Balance sheet continued

As at 31 March 2025


Notes

2025
£
13 months to
31 Mar 2024
£
Capital and reserves
Called up share capital: 100 100
Profit and loss account: 43,724 14,548
Shareholders funds: 43,824 14,648

For the year ending 31 March 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 7 December 2025
And Signed On Behalf Of The Board By:

Name: Sergey Belousov
Status: Director

Name: Igor Zharkov
Status: Director

The notes form part of these financial statements

BRITANNIA TIGER HEALTH LTD

Notes to the Financial Statements

for the Period Ended 31 March 2025

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

BRITANNIA TIGER HEALTH LTD

Notes to the Financial Statements

for the Period Ended 31 March 2025

  • 2. Employees


    2025
    13 months to
    31 Mar 2024
    Average number of employees during the period 2 0

BRITANNIA TIGER HEALTH LTD

Notes to the Financial Statements

for the Period Ended 31 March 2025

  • 3. Off balance sheet disclosure

    No

BRITANNIA TIGER HEALTH LTD

Notes to the Financial Statements

for the Period Ended 31 March 2025

4. Debtors


2025
£
13 months to
31 Mar 2024
£
Prepayments and accrued income 690 690
Other debtors 6
Total 690 696

BRITANNIA TIGER HEALTH LTD

Notes to the Financial Statements

for the Period Ended 31 March 2025

5.Creditors: amounts falling due within one year note


2025
£
13 months to
31 Mar 2024
£
Bank loans and overdrafts 207
Trade creditors 5,561
Taxation and social security 4,419
Accruals and deferred income 2,494 1,270
Other creditors 43,585
Total 51,847 5,689